Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02490293Completed
Randomised, double-blind trial of cefotiam and cefaclor in acute cholecystitis (2 arms). Primary endpoint: Number of Participants With Infectious Postoperative Complications at 30 days. Started Jun 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02490293.